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Background: Premature infants contribute substantially to infant morbidity and mortality especially in low resource 
settings.  Information on herbal remedy use, previous preterm birth and low social-economic status and their 
association with incidence of preterm birth in Kenya is scanty.  
Objectives: To determine the use of herbal remedy use in pregnancy, previous preterm birth and low socio-economic 
status as risk factors for Preterm Birth in Kitui County among the immediate post-partum mothers.  
Methods: Unmatched case control study with a 1:4 ratio of cases to controls. The study was done in Kitui and Mwingi 
District Hospitals.  A total of 107 mothers with preterm birth (cases) and 453 mothers with term births (controls) 
were eligible and administered structured interviews.  
Results: Of the sample, 98% of cases resided in rural areas compared to 90% of controls.  The cases had a higher 
parity and were more likely to belong to the lowest three and four levels of socio-economic status. On multivariate 
logistic regression analysis, predictors of preterm birth were: preeclampsia (OR=9.06 [2.60-31.63], p=0.001), 
previous preterm, (OR=9.31 [2.82-30.68], p<0.001), low socioeconomic status (OR=1.51 [1.05-2.16], p=0.03), herbal 
use in first trimester for 2-5 days (OR=11.10 [4.34-28.41], p<0.001), herbal use in first trimester for 6-10 days 
(OR=44.87,[4.99-403.87] p=0.001), and herbal use in second trimester for 6-10 days (OR=16.43 [4.53-59.57], 
p<0.001). Use of prescribed folic acid in second trimester for more than 31 days was associated with lower risk of 
preterm birth (OR=0.20 [0.12-0.34], p<0.001). 
Conclusion: Herbal use in pregnancy regardless of gestation, previous preterm birth and low socio-economic status 
and are risk factors for preterm birth in Kitui County Kenya.  Interventions targeted to reduction of these risk factors 
will be an important additional prong in the reduction of preterm birth.   
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1. Introduction 
Preterm labour is defined as the presence of uterine 
contractions of such frequency and intensity as to cause 
dilatation of the cervix prior to 37 completed weeks of 
gestation, leading to Preterm Birth (PTB) (Mahande et 
al. 2013). PTB is associated with increased infant 
mortality and morbidity.  Worldwide, approximately 
one in 10 babies is born prematurely.  This translates 
into about 15 million premature infants annually 
(Kinney et al. 2012), making PTB a major worldwide 
paediatric health problem.  It is estimated that in 
developed nations, one third of infant mortality is 
related to PTB (Lumley 2003).  Children born 
prematurely are also at a higher risk of long-term 
mental and physical disability, adversely affecting their 
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quality of life (Beck et al. 2010). Sub-Saharan Africa 
carries a disproportionately heavier burden of death 
and disabilities attributable to PTB. Estimates of 
incidences of PTB vary widely but are higher than in 
developed world (Beck et al. 2010), averaging about 
12% (Wessel et al. 1996) and  as high as 25% (Steer, 
2006). Unlike the developed nations, where most 
preventable risk factors are routinely controlled, 
mothers in Africa still have to contend with preventable 
causes of PTB, due to inadequate public health 
interventions. Due to the adverse outcomes of PTB, 
prevention of PTB remains an important intervention in 
obstetric care.  Prevention of preterm labour in the 
clinical setting is focussed on case management of 
individual mothers who present with symptomatic 
preterm labour.  Though this approach in itself does not 
lead to significant reduction on preterm deliveries, it 
affords the health professionals time for foetal lung 
maturity with antenatal steroids and transfer to tertiary 
facilities equipped to manage preterm infants. This 
prong does not mitigate the underlying factors of PTB. 
Hence, a need for a two pronged approach that includes 
identification and reduction of factors associated to 
PTB. 
Herbal remedies are commonly used by pregnant 
women in most African settings, and has been identified 
as a risk factor to PTB. Herbal remedies are defined as 
medicinal products containing aerial or underground 
parts of plants, or combinations of plant materials 
either in their crude form or as a refined plant 
preparation.  These products may also contain organic 
or inorganic ingredients that may not be of plant origin, 
such as honey (Bodeker et al. 2005). They constitute 
many phytochemicals, including carbohydrates, 
glycosides, sterols, flavonoids, tannins and alkaloids 
(Glover et al. 2003) many of which are biologically 
active. Herbs could cause adverse pregnancy outcomes 
due to adulteration, contamination with unlabelled 
toxins, inappropriate formulations and interaction 
between conventional medications and herbs (Elvin-
Lewis 2001). In Kenya the use of herbal remedies is 
deep rooted and on an upward trend.  In addition to the 
traditional herbalists in the rural areas, many herbal 
practitioners are setting up shops in the urban areas as 
well.   
Obstetric and gynaecological history plays an important 
role in predicting the incidence of preterm birth.  
History of preterm birth and previous induced abortion 
are strongly associated with preterm birth.  Other 
conditions such as preeclampsia, eclampsia, ante-
partum haemorrhage and placenta praevia put the 
mother at risk for preterm birth (Feresu et al. 2004) 
Low social-economic status is an important risk factor 
for preterm birth in Sub-Saharan Africa.  This is because 
other controllable risk factors for preterm birth are 
associated with low income.  Poor maternal nutrition is 
a significant risk factor for preterm birth.  In fact, 
incidence of preterm birth has been known to rise in the 
months of drought due to poor access to nutrition 
(Rayco-Solon et al. 2005). Moreover, low maternal body 
mass index (BMI) is an independent determinant of 
preterm birth (Goldenberg et al. 2008). Low social-
economic status is also linked to risky maternal 
lifestyles, such as tobacco use and alcohol consumption, 
both of which are associated with a higher incidence of 
preterm birth (Cox et al. 2013) 
We undertook a study to determine exposure to herbal 
remedies in pregnancy, previous preterm birth and low 
socio-economic status as risk factors for preterm birth 
and other associated risk factors in Kitui County Kenya. 
2. Methodology 
2.1 Study Design: This was a non-matched hospital 
based case control study with a ratio of 1:4 for cases to 
controls.  
2.2 Study setting: The Kitui and Mwingi District 
hospitals of Kitui County Kenya.  Kitui County is located 
in the South of the former Eastern Province.  It is a 
semi-arid region with sporadic rainfall, which impacts 
negatively on subsistence farming, which is the major 
economic activity. This county was selected for this 
study because none of the studies reviewed have been 
conducted in this region on risk factors for preterm 
birth. It was also important because the cultural 
practices of the people in this region include use of 
herbal remedies. It has two major urban centres 
namely, Kitui and Mwingi.  Kitui and Mwingi District 
hospitals are the two largest public hospitals in the 
county. 
2.3 Study population: The cases were immediate 
post-partum mothers who presented to Kitui and 
Mwingi District Hospitals within the study period 
between May and August, 2014, had a PTB (delivery at 
less than 37 completed weeks of gestation). Controls 
immediate post-partum mothers who presented to Kitui 
and Mwingi District Hospitals and had a term live 
delivery (delivery more or equal to 37 completed weeks 
of gestation). Very sick or unconscious mothers or those 
who did not give informed consent as well as those who 
could not communicate either in Kiswahili or English 
were excluded from the study. Mothers of postmature 
infants (more or equal to 42 weeks gestation) were also 
excluded from the control group.  
2.4 Sample Size, Sampling Procedure and 
Participant recruitment 
The study was designed to detect an Odds Ratio of two 
or more, with 80% or greater statistical power, 
exposure prevalence of 15% at 95% confidence level. A 
sample size of cases (n) = 115 and that of controls (n) 
=460 was adequate for this purpose (Brian et al. 2012).   
Participants were recruited on a daily bases as they 
attended the hospitals over a period of three months. To 
recruit the participants took place in the postnatal 
wards, Assessment eligibility and informed consent 
sought for the study. All eligible participants were 
interviewed and prescription drug information 
extracted from the Mother and Child Booklet.   
2.5 Data Variables 
The level of education of the mothers was classified in 
to four categories depending on the highest level of 
education attained by individual participant, none (for 
those who had had no education), primary, secondary 
and tertiary. 
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Table 1: Baseline characteristics of the mothers who had preterm birth (cases) and those who had term birth 
(controls) in Kitui County (2014) 
Maternal Characteristics Cases n=107 (%) Controls n=453 (%) Total (%) p value 
Mean age [SD] 25.4 [7.1] 24.4 [5.4] 25.2 [5.8] 0.116 
Level of education           
None 7 (6.5) 23 (5.1) 30 (5.4) 0.168 
Primary 63 (58.9) 222 (49) 285 (50.9) 
 
Secondary 29 (27.1) 174 (38.4) 203 (36.3) 
 
Tertiary 8 (7.5) 34 (7.5) 42 (7.5) 
 
Residence                           
Rural 105 (98.1) 406 (89.6) 511 (91.3) 0.005 
Urban 2 (1.9) 47 (10.4) 49 (8.8) 
 
Housing                    
Stone house 8 (7.5) 45 (9.9) 53 (9.5) 0.033 
Tin roof with brick wall 51 (47.7) 272 (60.0) 323 (57.7) 
 
Tin roof with mud wall 41 (38.3) 114 (25.2) 155 (27.7) 
 
Thatched house 7 (6.5) 22 (4.9) 29 (5.2) 
 
Previous pregnancies               
0 36 (33.6) 142 (31.4) 178 (31.8) 0.04 
1 27 (25.2) 112 (24.7) 139 (24.8) 
 
2 18 (16.8) 127 (28.0) 145 (25.9) 
 
3 12 (11.2) 44 (9.7) 56 (10.0) 
 
> 3 14 (13.1) 28 (6.2) 42 (7.5) 
 
Number of ANC visits              
0 9 (8.4) 3 (0.7) 12 (2.1) 0.085 
1 11 (10.3) 23 (5.1) 34 (6.1) 
 
2 37 (34.6) 44 (9.7) 81 (14.5) 
 
3 42 (39.3) 129 (28.5) 171 (30.5) 
 
4 5 (4.7) 180 (39.7) 185 (33.0) 
 
>4 3 (2.8) 74 (16.3) 77 (13.8) 
 
Tobacco use                           
No 106 (99.1) 452 (99.8) 558 (99.6) 0.266 
Yes 1 (0.9) 1 (0.2) 2 (0.4)  
Alcohol use                            
No 96 (89.7) 430 (94.9) 526 (93.9) 0.043 
Yes 11 (10.3) 23 (5.1) 34 (6.1)  
Prior PTB, miscarriage or pregnancy termination 
No 95 (88.8) 447 (98.7) 542 (96.8) <0.001 
Yes 12 (11.2) 6 (1.3) 18 (3.2)  
Preeclampsia                          
No 97 (90.7) 448 (98.9) 545 (97.3) <0.001 
Yes 10 (9.4) 5 (1.1) 15 (2.7)  
Vaginal candidiasis                
No 97 (90.7) 410 (90.5) 507 (90.5) 0.963 
Yes 10 (9.4) 43 (9.5) 53 (9.5)  
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Type of housing was used as a surrogate indicator for 
socio-economic status. Mothers who had had a previous 
preterm birth, miscarriage or termination of pregnancy 
were classified together. For all medications and herbal 
remedies, trimester in which the first dose was taken 
and the duration for which the medication was taken 
were combined to make one composite variable. Timing 
of medication use was classified as first trimester (one 
to 13 weeks), second trimester (14 to 27 weeks) or 
third trimester (after 27 weeks).  Duration of use was 
classified as “once to 1 day”, “2 to 5 days”, “6 to 10 
days”, “11-30 days” or “more than 31 days”.   
2.6 Data Collection and Management 
A structured questionnaire was administered to 
participants to collect data to determine maternal 
baseline characteristics and exposure to herbal 
remedies, every participant underwent a structured 
interview with the use of a questionnaire.  Prescription 
medication data was abstracted from the Mother and 
Child booklet. Data variables were entered into 
Microsoft Excel 2010 spread sheet using the participant 
number as the identification (ID) number.   De-
identified data was exported to STATA version 12 for 
analysis. 
2.7 Data analysis 
Descriptive data analysis was done for socio-
demographic variables.  Mean and standard deviation 
were determined for age of the mothers.  Counts and 
percentages were used to summarize categorical 
variables.  Logistic regression was done to determine 
significant medication-related risk factors for preterm 
birth. To control for confounding, a multivariate 
analysis was done by manual forward stepwise model 
building until a parsimonious model was achieved. Odds 
ratios and 95% confidence intervals were reported and 
p-values of 0.05 and less were considered statistically 
significant.  
2.8 Ethical considerations  
The Kenyatta National Hospital/University of Nairobi 
Ethics and Research Committee (KNH/UoN-ERC) gave 
ethical approval for the study (Reference No. 
P77/02/2014) and permission to carry out the study 
were sort from Kitui and Mwingi District Hospitals. 
Written informed consent was obtained from each 
participant.  All the filled questionnaires were safely by 
the Principal investigator and electronic data were pass 
word protected. Only de-identified data was analysed. 
3.  Results 
3.1 Sample baseline characteristics 
The baseline characteristics are summarized in Table 1.  
The mean age of the participants in this study was 25.2 
(±5.8) years.  The cases had a mean age of 25.4 (±7.1) 
years and the controls 24.4 (±5.4) years. There was no 
significant difference in mean age across the two 
groups. Diagnosis of preeclampsia was significantly 
higher among the cases 9.4% (10/107) compared to 
controls 1.1% (5/453) [p<0.001]; previous PTB, 
pregnancy termination or miscarriage were higher in 
cases 11.2% (12/107) compared to controls 1.3% 
6/453 [p<0.001]; The cases were more likely to belong 
to the two lowest socio-economic status 44.8% 
(48/107) than the controls 30.0%) (136/453) 
[p=0.033].  Parity of more than three was significantly 
more common among the cases 24.3% (26/107) 
compared to controls 15.9% (72/4530 [p=0.04].  There 
was no statistically significant difference between the 
two groups on the level of education. Most of the cases 
98.1% (105/107) were drawn from rural areas 
compared to 89.6% (406/43) of controls [p=0.005]. 
The controls were more likely to have met the 
recommended at least four antenatal clinic visits 56.0% 
(254/453) compared to 7.5% (8/107 of the cases 
[p=0.085], although there was no significant difference 
across the two groups. Cases had a significantly higher 
proportion of alcohol users 10.3% (11/107) compared 
to controls 5.1% [23/453] [p=0.043]. 
3.2 Herbal remedy use in pregnancy 
From Table 2, the cases were 16 times likely to have 
used herbal remedies at all in pregnancy than the 
controls (OR=16.2; 95% CI [6.52-35.6]). Cases were 15 
times more likely to have used herbal remedies in the 
first trimester compared to the controls (OR=15.7; 95% 
CI [7.34-33.6]). Herbal use in the first trimester for two 
to five days had a 12 times higher risk of preterm birth 
(OR=12.01; 95% CI [5.1-28.3]) while use for six to 10 
days increased the risk to 36 times (OR=36.53; 95% CI 
[4.52-295.36]). Finally, cases were 10 times more likely 
to have used herbal remedies in the second trimester 
for six to 10 days (OR=10.31; 95% CI [3.11-34.15]) 
Although this study was not intended to identify 
individual herbal remedies, some herbal remedies were 
frequently mentioned.  These included “Mwarubaine” 
(Azadirachta indica) leaves and bark extracts   
“muembe” (Mangifera indica) leaves and bark extracts, 
and leaves of “mukawa” (Carissa edulis) and “kiluma” 
(Aloe vera). The following  reasons were given for 
taking herbal remedies: prescribed by a relative 
including a parent, herbal remedy was considered safe 
for use in pregnancy, lack of alternative due to 
inaccessibility of health facilities, to strengthen the 
pregnancy, to reduce length of labour, and because it 
was recommended by other persons in the community. 
Other reasons given included recommendation by a 
traditional healer and adherence to cultural practices. 
3.3 Multivariate analysis of risk factors for PTB 
Diagnosis of preeclampsia was associated with more 
than 9 times higher risk for PTB OR=9.06 (p=0.001; 
95% CI: 2.60-31.63), as was report of previous preterm 
birth OR=9.31 (p<0.001: 95% CI: 2.82-30.68). Low 
socioeconomic status was associated with a 51% higher 
risk for PTB OR=1.51 (p=0.03; 95%CI: 1.05-2.16). 
Herbal use in first trimester for 2-5 days was associated 
with 11 times higher risk OR=11.10 ( p<0.001: 95% CI: 
4.34-28.41), herbal use in first trimester for 6-10 days 
nearly 45 times higher risk OR=44.87 (p=0.001;95%CI: 
4.99-403.87), and herbal use in second trimester for 6-
10 days more than 16 times higher risk for PTB 
OR=16.43(p<0.001; 95% CI: 4.53-59.57). Prescribed 
folic acid in second trimester for more than 31 days was 
associated with 80% lower risk of PTB (OR=0.20, 
p<0.001; 95% CI: 0.12-0.34), Table 3 and Figure 1.
 Kaburi et al, Afr. J. Pharmacol. Ther. 2015. 4(4): 135-142 
 
A KeSoBAP Publication ©2013. All rights reserved.  ISSN 2303-9841 
   139 
Table 2: Herbal remedy use in mothers who had preterm birth (cases) and those who had term birth (controls) in 
Kitui County (2014) 
Composite Variable  
Cases 
n=107(%) 
Controls 
n=453 (%) 
OR (95%CI) p-Value 
Herbal use, first trimester for one day 1(0.9) 1(0.2) 4.26(0.26-68.72) 0.307 
Herbal use, first trimester for 2-5 days 19(17.8) 8(1.8) 12.01(5.1-28.3) <0.001 
Herbal use, first trimester six to 10 days 8(7.5) 1(0.2) 36.53(4.52-295.36) 0.001 
Herbal use, second trimester for 6-10 days 9(8.4) 4(0.9) 10.31(3.11-34.15) <0.001 
Report of herbal use in the first trimester 28(26.2) 10(2.2) 15.7(7.34-33.6) <0.001 
Report of herbal use in pregnancy 37(34.6) 14(3.1) 16.2 (6.52-35.6) <0.001 
 *Significant p-values in bold; CI confidence interval 
Table 3: Multivariate analysis of factors associated with preterm birth in mothers who had preterm birth (cases) and 
those who had term birth (controls) in Kitui County (2014) 
Variable Crude OR (95%CI) p-value Adjusted OR (95%C)* p-value 
Preeclampsia 9.21 (3.09-27.63) 0.000 9.06 (2.60-31.63) 0.001 
Previous preterm birth 9.41 (3.45-25.69) 0.000 9.31 (2.82-30.68) 0.000 
Housing 1.45 (1.08-1.95) 0.013 1.51 (1.05-2.16) 0.03 
Residence 0.16 (0.04-0.72) 0.013 - - 
Alcohol use 2.14 (1.11-4.54) 0.047 - - 
Tobacco use 4.26 (0.26-68.72) 0.307 - - 
Number of Previous pregnancies 1.07 (0.90-1.26) 0.445 - - 
Herbal use in first trimester for 2-5 days 12.01 (5.10-28.30) 0.000 11.10 (4.34-28.41) 0.000 
Herbal use in second trimester for 6-10 
days 
10.31 (3.11-34.16) 0.000 16.43 (4.53-59.57) 0.000 
Herbal use in first trimester for 6-10 
days 
36.53 (4.52-295.30) 0.001 44.87 (4.99-403.87) 0.001 
Herbal use in the first trimester once 4.26 (0.26-68.72) 0.307 - - 
Prescribed ferrous sulphate 2nd  
trimester for >31 days 
0.19 (0.12-0.30) 0.000 - - 
Prescribed Folic acid, 2nd trimester  > 31 
days 
0.18 (0.12-0.28) 0.000 0.20 (0.12-0.34) 0.000 
Prescribed metronidazole 2nd trimester 
2-5 days 
6.57 (2.44-17.67) 0.000 - - 
Prescribed amoxicillin 1st  trimester 2-5 
days 
0.09 (0.01-0.66) 0.018 - - 
Prescribed omeprazole 2nd trimester 6-
10 days 
6.51 (2.03-39.41) 0.042 - - 
Self-medication amoxicillin first 
trimester 2-5 days 
4.42 (1.40-14.00) 0.011 - - 
Self-medication chlorpheniramine 1st 
trimester 2-5 days 
4.36 (2.01-17.73) 0.040 - - 
Self-medication magnesium trisilicate 
1st trimester 2-5 days 
8.91 (2.19-36.23) 0.002 - - 
Self-medication paracetamol 1st 
trimester 2-5 days 
3.78 (1.24-11.51) 0.019 - - 
*Pseudo R2=0.2768, Significant p-values in bold, CI confidence interval  
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     Figure 1: Summary of factors associated to preterm birth in Kitui County, Kenya (2014) 
4. Discussion 
The main findings of this study are that previous 
preterm birth, low socio-economic status and herbal 
use in pregnancy regardless of gestation are associated 
with a higher likelihood of preterm birth among 
pregnant women in Kitui County.  
Diagnosis of preeclampsia was associated with more 
than nine times higher risk of preterm birth compared 
to mothers who did not have preeclampsia. This is more 
than twice the risk reported from Ardabil, Iran (Alijahan 
et al. 2014). Another study by Bilano et al in low and 
middle income countries found out that preeclampsia 
was a significant risk factor for PTB (Bilano et al. 2014). 
Over 11% of the mothers with PTB had had either a 
previous PTB, pregnancy termination or miscarriage 
compared to only 1 % of the control mothers. Prior 
preterm, pregnancy termination or miscarriage was a 
significant risk factor for PTB in this study. This 
corroborates findings of a Brazilian study that found 
that previous abortion carried a 39% more risk for PTB 
(Passini et al. 2014). A study in Scotland found that 
previous abortion was associated with 12% risk in 
preterm birth (Oliver-Williams et al. 2013). Di Renzo et 
al reported nearly a doubling of risk for PTB by 
previous abortion (Di Renzo et al. 2011). Both abortion 
and previous PTB were reported to be significantly 
more frequent for mothers with PTB (16.3%) than 
mothers with term birth (11.5%) (Winer et al. 2009). 
Mothers with three or more previous pregnancies in 
this study were 24% among the cases compared to 16% 
among the controls. Though number of previous 
pregnancies was not statistically significant after 
multivariate analysis, multiparity has been reported as 
a risk factor for preterm birth. An Iranian study found 
that there was a 56% increase in the risk for PTB for 
every increase in the number of gravidities (Poorolajal 
et al. 2014).  
Low socio-economic was associated with significantly 
higher risk for PTB. Nearly 45% of the cases belonged to 
the lower two tiers of the socio-economic status 
compared to about a third of the controls. Low socio-
economic status is a risk factor for PTB probably 
because other risk factors are linked to poor income. 
Inadequate maternal nutrition, low body mass index 
and manual labour as well as mental and physical 
stress, among others, are higher in poor populations. 
These are known independent risk factors for PTB 
(Rayco-Solon et al. 2005, Dole et al. 2004).  
Among the cases, 10% reported use of alcohol 
compared to 5% among the controls. On multivariate 
analysis, this association ceased to be significant. 
However, a British cohort study found that women who 
used alcohol had a two and a half times higher risk for 
PTB than non-drinkers (Srikartika and O’Leary 2014).  
Prescription medications, such as ferrous sulphate, 
metronidazole, omeprazole and amoxicillin were 
significant risk factors on bivariate analysis, though 
they were not significant on multivariate analysis. This 
also applied to self-medications, such as amoxicillin, 
chlorpheniramine and magnesium trisilicate.  
Prescribed folic acid from the second trimester for more 
than 31 days was associated with lower risk for PTB. On 
multivariate analysis, this study found that others on 
folic acid were 80% less likely to have PTB compared to 
mothers not on folic acid. Mothers needed to use it for 
more than 31 days for any advantage to be noted. This 
-2 -1 0 1 2 3 4 5
Preeclampsia
Previous preterm
Low socio-economic status
Herbal use 1st trimester, 2-5 days
Herbal use 1st trimester, 6-10 days
Herbal use 2nd trimester, 6-10 days
Prescribed folic acid 2nd trimester >31days
β-coefficient
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corroborated findings of other studies that concluded 
that folic acid use in pregnancy appeared to be 
protective against PTB (Verstappen et al. 2013), 
(Lupattelli et al. 2014). A Chinese study also reported a 
14% risk reduction with use of folic acid (Li et al. 2014).  
The main finding of this study are that herbal remedy 
use was associated with a higher risk of PTB in Kitui 
County.  The use of herbal remedies in pregnancy in 
Kitui County is common and deleterious. Exposure to 
herbal remedies in the first trimester was associated 
with very high risk for PTB. Longer use of herbal 
remedies was associated with higher risk. It was 
observed that herbal decoctions prepared at home and 
herbal remedies acquired from herbal clinics were the 
most commonly used by the mothers.  Clearly then, 
herbal remedy use in pregnancy is a significant risk 
factor for PTB, especially in the first and second 
trimesters. Herbal remedies contain many 
unstandardized bioactive xenobiotics and secondary 
plant metabolites many of which may have toxic effects 
to the developing foetus.  In addition, herbal decoctions 
preparation at home may not adhere to stringent good 
manufacturing practices.  Microbial contamination may 
occur during extraction, packaging and while 
dispensing, exposing the mother to dangerous 
infections. In addition, herbal preparations may also 
have contamination with heavy metals such as lead and 
mercury, depending on the source (Karri, Saper, and 
Kales 2008).  
The results of this study corroborates findings of an 
Italian study that showed herbal remedy use is 
associated with increased adverse pregnancy outcomes, 
including PTB (Cuzzolin et al, 2010).  Another study on 
use of Chinese herbal medicines in pregnancy among 
the Taiwanese reported that pregnant women with 
threatened abortion were more likely to have used 
herbal remedies than other pregnant women (Chuang 
et al, 2007). A multicentre study on herbal supplements 
in pregnancy also found that mother’s length of 
gestation was affected by herbal use. Mothers using 
herbal remedies were twice as likely to have PTB as 
non-users (Facchinetti et al. 2012). It is therefore 
important for health providers to be sensitized on local 
herbs and their use in pregnancy. 
5. Conclusion 
Herbal use in pregnancy regardless of gestation, 
previous preterm birth and low socio-economic status 
and are risk factors for PTB in Kitui County Kenya.  
Interventions targeted to reduction of these risk factors 
will be an important additional prong in the reduction 
of PTB. 
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